Skip to content
DataLookout
Menu

NCT04435444

Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 12 versions: 11 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 12 words
    • Trial completed
    • Primary completion date changed from estimate of Jun 2027 to Nov 10, 2026
  2. Notable Primary and study completion dates: Jun 2026 to Jun 2027v11
  3. Notable Primary and study completion dates: Jun 2025 to Jun 2026v10
  4. Notable Primary and study completion dates: Jun 2024 to Jun 2025v9
  5. Notable Primary and study completion dates: Jun 2023 to Jun 2024v8
Show 5 earlier versionsHide 5 earlier versions
  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 72 to confirmed 19
    • Site details revised
    v6
  2. Notable Primary and study completion dates: Jun 2022 to Jun 2023v5
  3. Minor Site details revisedv4
  4. Notable Eligibility criteria expanded, about 5 wordsv3
  5. Notable Eligibility criteria expanded, about 2 words
    • Collaborators: 2 to 1
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

number of enrolled participants completing at least one psychotherapy session out of the planned three.
Timeframe: 1 year

Arms and interventions

Masterful supportive careExperimental

This intervention uses teachings, discussions, and exercises about personal experiences that focus on specific topics related to meaning and cancer. For example, we may discuss what is meaningful in your life, how you identify yourself before and after cancer, and your hopes for the future. The Masterful intervention is available in both English and Arabic, and it will be delivered by a trained bilingual member of the study team. It includes 3 weekly (or at participant's preference) 1-hour sessions with a member of the study team. The sessions for either the treatment or the control arm will take place in-person in a private room at MSKCC or via teleconference, depending on the patients preference. Meeting one-on-one with an interventionist was feasible in our pilot study and will enhance relationship-building between interventionist and patient. Participants will have the option to meet with the interventionist via teleconference in order to reduce in-person contact burden.

Attention control supportive careActive comparator

This intervention uses the American Cancer Society's patient education materials. These sessions will include discussions about managing a self-identified current problem in your life. The attention control supportive care intervention is available in both English and Arabic, and it will be delivered by a trained bilingual member of the study team. It includes 3 weekly (or at participant's preference) 1-hour sessions with a member of the study team. The sessions for either the treatment or the control arm will take place in-person in a private room at MSKCC or via teleconference, depending on the patients preference. Meeting one-on-one with an interventionist was feasible in our pilot study and will enhance relationship-building between interventionist and patient. Participants will have the option to meet with the interventionist via teleconference in order to reduce in-person contact burden.

Other: Masterful supportive care, Attention control supportive care

Sites

1 site in 1 country

  • Memorial Sloan Kettering Cancer CenterNew York, New York, United States